C4 THERAPEUTICS INC (CCCC) Stock Balance Sheet
NASDAQ:CCCC - Nasdaq - US12529R1077 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.29M | 55.50M | 126.59M | 29.80M | 76.10M | |||
| Marketable Securities | 163.79M | 189.41M | 127.09M | 246.40M | 233.20M | |||
| Receivables | 8.03M | 3.10M | 11.80M | 1.50M | 5.70M | |||
| Other Current Assets | 9.42M | 9.76M | 5.71M | 9.90M | 10.70M | |||
| Total Current Assets | 232.53M | 257.77M | 271.19M | 287.60M | 325.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 61.36M | 63.38M | 71.09M | 77.50M | 35.10M | |||
| Investments And Advances | 19.62M | 22.36M | 28.01M | 61.00M | 142.20M | |||
| Other Non-Current Assets | 6.01M | 6.10M | 6.17M | 4.80M | 3.80M | |||
| Total Non-Current Assets | 86.99M | 91.83M | 105.26M | 143.20M | 181.10M | |||
| TOTAL ASSETS | 319.52M | 349.60M | 376.45M | 430.80M | 506.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 2.30M | N/A | |||
| Accrued Expenses | 16.67M | 23.27M | 23.81M | 22.40M | 14.50M | |||
| Accounts Payable | 683.00K | 1.33M | 1.45M | 1.20M | 4.50M | |||
| Other Current Liabilities | 23.46M | 20.58M | 17.51M | 18.70M | 32.20M | |||
| Total Current Liabilities | 40.82M | 45.18M | 42.77M | 44.50M | 51.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 9.20M | 10.80M | |||
| Other Non-Current Liabilities | 83.56M | 88.44M | 87.57M | 87.90M | 55.10M | |||
| Total Non-Current Liabilities | 83.56M | 88.44M | 87.57M | 97.10M | 66.00M | |||
| TOTAL LIABILITIES | 124.38M | 133.62M | 130.34M | 141.60M | 117.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -660.02M | -633.70M | -528.38M | -395.90M | -267.70M | |||
| Additional Paid In Capital | 855.11M | 849.63M | 774.62M | 689.30M | 658.10M | |||
| Common Shares | 7.00K | 7.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 43.00K | 53.00K | -127.00K | -4.10M | -800.00K | |||
| Shares Outstanding | 70.99M | 70.63M | 60.47M | 49.00M | 48.70M | |||
| Tangible Book Value per Share | 2.75 | 3.06 | 4.07 | 5.90 | 8.00 | |||
| Total Shareholders' Equity | 195.14M | 215.99M | 246.11M | 289.20M | 389.60M | |||
| TOTAL LIABILITIES AND EQUITY | 319.52M | 349.60M | 376.45M | 430.80M | 506.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.03 | 0.03 | |||
| Current Ratio | 5.70 | 5.71 | 6.34 | 6.46 | 6.36 | |||
| Return On Assets (ROA) | -32.32% | -30.12% | -35.20% | -29.75% | -16.55% | |||
| Return On Equity (ROE) | -52.92% | -48.76% | -53.83% | -44.32% | -21.53% | |||
All data in USD , ROIC based on taxRate of 0.21